// App-Quantinova.ai

404 : Impact of Age on Levodopa dosage regimes in Idiopathic Parkinson’s Disease

Researchers

Presenter

  • L. Scourfield

Principal Investigators

  • S. Sultana

  • C. Thomas

  • B. Mohamed

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

Biomarkers

  • N/A

Drug/Treatment

  • Levodopa

Outcome

  • N/A


Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A